Simufilam: Clinical Trials

4 trials of Simufilam, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed. 4 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 14Completed 4

Follow Simufilam: new trials by email Literature Review of Simufilam trials Research Report on Simufilam

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Pharmacokinetic Study of Simufilam in Subjects With Impaired Hepatic Function
Simufilam - Hepatic Insufficiency
Phase 1CompletedCassava Sciences, Inc.272024-06-262025-01-07
Open-label Study of the Absorption, Metabolism, and Excretion of [14C]-Simufilam Following a Single Oral Dose in Healthy Male Subjects
Simufilam - Absorption, Metabolism
Phase 1CompletedCassava Sciences, Inc.82024-02-072025-03-20
Food Effect and Bioequivalence Study of Simufilam Tablets in Healthy Volunteers
simufilam - Healthy Volunteers
Phase 1CompletedCassava Sciences, Inc.242021-05-042023-08-22
A Safety Study of PTI-125 in Healthy Volunteers
50 mg PTI-125, 100 mg PTI-125, 200 mg PTI-125 - Alzheimer Disease, Early Onset, Alzheimer Disease
Phase 1CompletedPain Therapeutics242017-08-182021-05-10

Conditions studied

Alzheimer Disease (1)  ·  Hepatic Insufficiency (1)

Sponsors

Cassava Sciences, Inc. (3)  ·  Pain Therapeutics (1)

Countries

United States (4)

Top investigators

George J Atiee, MD (1)  ·  Robert G Bass, MD (1)

NIH funding

R44AG056166 (1)